AU Patent

AU2011209788C1 — Antiviral therapy

Assigned to ViiV Healthcare Co · Expires 2014-08-28 · 12y expired

What this patent protects

The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or…

USPTO Abstract

The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.

Drugs covered by this patent

Patent Metadata

Patent number: AU2011209788C1
Jurisdiction: AU
Classification: —
Expires: 2014-08-28
Drug substance claim: No
Drug product claim: No
Assignee: ViiV Healthcare Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.